Table 1.
Study group | CT mean | ΔCT | ΔΔCT | 2−ΔΔCT | |
---|---|---|---|---|---|
Gapdh | Slc5a8 | ||||
Gonad-intact female | |||||
Control | 23.530 | 33.406 | 9.876 | −2.708 | 6.534 |
VPA-treated | 23.083 | 30.251 | 7.168 a | ||
Gonad-intact male | |||||
Control | 22.905 | 29.452 | 6.547 b | 4.034 | 0.061 |
VPA-treated | 22.982 | 33.563 | 10.581 c | ||
Gonadectomized female | |||||
Control | 22.675 | 29.403 | 6.728 | 0.046 | 0.969 |
VPA-treated | 24.831 | 31.604 | 6.774 | ||
Gonadectomized male | |||||
Control | 25.436 | 29.649 | 4.213 | 4.545 | 0.043 |
VPA-treated | 22.319 | 31.077 | 8.758 d |
ap = 0.03, significant compared with the gonad-intact female control.
bp = 0.004, significant compared with the gonad-intact female control.
cp = 0.02, significant compared with the gonad-intact male control.
dp = 0.03, significant compared with the castrated male control.